| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 20/09/2021 | Lote 54 Pfizer(6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 5 | 118 | 0 | 21 | 0 | 145 |
| 20/09/2021 | Lote 54 Coronavac (10d) | Butantan/CoronaVac | 140 | 300 | 0 | 0 | 0 | 440 |
| 22/09/2021 | Lote 55 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 225 | 0 | 5 | 0 | 230 |
| 22/09/2021 | Lote 55 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 178 | 232 | 0 | 0 | 0 | 414 |
| 23/09/2021 | Lote 56 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 29 | 0 | 0 | 0 | 29 |
| 24/09/2021 | Lote 57 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 105 | 0 | 4 | 0 | 109 |
| 24/09/2021 | Lote 57 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 217 | 0 | 19 | 0 | 236 |
| 28/09/2021 | Lote 58 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 4 | 122 | 0 | 0 | 0 | 126 |
| 29/09/2021 | Lote 59 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 45 | 0 | 5 | 0 | 50 |
| 29/09/2021 | Lote 59 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 12 | 2 | 85 | 0 | 99 |
| 02/10/2021 | Lote 60 Coronavac (10d) | Butantan/CoronaVac | 80 | 30 | 0 | 0 | 0 | 110 |
| 02/10/2021 | Lote 60 AstraZeneca (5d) | Fiocruz/Oxford/AstraZeneca | 15 | 235 | 0 | 7 | 0 | 257 |
| 05/10/2021 | Lote 61 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 20 | 214 | 0 | 5 | 0 | 245 |
| 05/10/2021 | Lote 61 Coronavac (10d) | Butantan/CoronaVac | 10 | 50 | 0 | 0 | 0 | 60 |
| 07/10/2021 | Lote 62 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 90 | 0 | 0 | 0 | 90 |
| 07/10/2021 | Lote 62 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 130 | 282 | 0 | 0 | 0 | 432 |
| 13/10/2021 | Lote 63 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 10 | 0 | 0 | 0 | 10 |
| 13/10/2021 | Lote 63 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 52 | 425 | 0 | 0 | 0 | 492 |
| 13/10/2021 | Lote 63 Coronavac (10d) | Butantan/CoronaVac | 10 | 170 | 0 | 0 | 0 | 180 |
| 15/10/2021 | Lote 64 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 1 | 65 | 0 | 0 | 0 | 66 |
| 20/10/2021 | Lote 65 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 46 | 350 | 0 | 2 | 0 | 398 |
| 25/10/2021 | Lote 66 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 115 | 300 | 0 | 0 | 0 | 498 |
| 28/10/2021 | Lote 67 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 5 | 0 | 1 | 0 | 6 |
| 28/10/2021 | Lote 67 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 44 | 250 | 0 | 0 | 0 | 294 |
| 28/10/2021 | Lote 67 Coronavac (10d) | Butantan/CoronaVac | 10 | 460 | 0 | 0 | 0 | 470 |
| 09/11/2021 | Lote 68 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 0 | 10 | 0 | 0 | 0 | 10 |
| 09/11/2021 | Lote 68 Coronavac (10d) | Butantan/CoronaVac | 0 | 40 | 0 | 0 | 0 | 40 |
| 17/11/2021 | Lote 69 Astrazeneca (5d) | Fiocruz/Oxford/AstraZeneca | 15 | 150 | 0 | 0 | 0 | 165 |
| 17/11/2021 | Lote 69 Pfizer (6d) | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 94 | 459 | 0 | 0 | 0 | 594 |
| 19/11/2021 | Lote 70 Coronavac (10d) | Butantan/CoronaVac | 170 | 300 | 0 | 0 | 0 | 470 |
